Advertisement

Dietary fats, carbohydrates and vascular disease: Sri Lankan perspectives

      Abstract

      The recent estimates for mortality from cardio and cerebrovascular diseases (CVD) for Sri Lanka––524 deaths per 100 000––is higher than that observed in many Western economies. However, neither an excessive total fat intake nor an increase in the more traditional plasma lipid markers, total and LDL cholesterol (LDL-c) levels may fully explain the increased vulnerability to CVD in this population. The average total fat intake of Sri Lankans is 25 percent of total energy (en%) and the reported total and LDL-c values are 4.9 and 2.5 mmol/l, respectively. With regard to the type of dietary fatty acids, the ratio of saturated/polyunsaturated fatty acids (PUFAs) in the average Sri Lankan diet is 9/1 as compared with the current recommended ratio of <1/1. In spite of an adequate total fat intake (25 en%), the relatively low intake of PUFAs in association with a high carbohydrate diet (65 en%), appear to be resulting in similar metabolic outcomes to those of very low fat diets (VLFD, <15 en% from fat), as reflected by high triglycerides and low HDL levels. Metabolic abnormalities including elevated postprandial hyperlipidemia, more atherogenic lipoprotein particles, hyperglycemia with resultant hyperinsulinemia and increased oxidative stress are likely to be more relevant in such settings. The application of novel biomarkers for example, lipoprotein measurements in the postprandial state, LDL particle size, estimates of endothelial dysfunction, soluble markers of inflammation and coagulability status may provide further insight into cardiovascular disease states in populations where the dietary matrix represents high intakes of highly digestible carbohydrates and saturated fat.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. Mendis S. Cardiovascular research in Sri Lanka––a review and bibliography, Colombo, Sri Lanka: Ministry of Health, 1998:1–135.

        • Mendis S.
        • Samarajeewa U.
        • Thattil R.O.
        Coconut fat and serum lipoproteins: effects of partial replacement with unsaturated fats.
        Br. J. Nutr. 2001; 85: 583-589
        • Haumann B.F.
        Lauric oils have their own niche.
        Inform. 1992; 3: 1080-1093
        • Changbumrung S.
        • Buavatana T.
        • Migasena P.
        Alpha-tocopherol in vegetable oils.
        Int. J. Vitamin Nutr. Res. 1980; 50: 242-246
      2. American Heart Association, Summary of the scientific conference on dietary fatty acids and cardiovascular health. Circulation 2001;103:1034–9.

        • Perera A.
        • Atukorale D.N.
        • Sivayogan S.
        • et al.
        Prevalence of skin diseases in suburban Sri Lanka.
        Ceylon Med. J. 2000; 45: 123-128
      3. Lands WEM. Fish and human health, London: Academic Press, 1986:20–5.

        • Riccardi G.
        • Rivellese A.A.
        Dietary treatment of the metabolic syndrome––the optimal diet.
        Br. J. Nutr. 2000; 83: S143-148
        • Barton M.
        • Carmona R.
        • Krieger J.E.
        • et al.
        Endothelin regulates angiotensin-converting enzyme in the mouse kidney.
        J. Cardiovasc. Pharmacol. 2000; 36: S244-247
        • Arechaga G.
        • Martinez J.M.
        • Prieto I.
        • et al.
        Serum aminopeptidase A activity of mice is related to dietary fat saturation.
        J. Nutr. 2001; 131: 1177-1179
        • Reaux A.
        • Iturrioz X.
        • Vazeux G.
        • et al.
        Aminopeptidase A, which generates one of the main effector peptides of the brain renin-angiotensin system, angiotensin III, has a key role in the central control of arterial blood pressure.
        Biochem. Soc. Trans. 2000; 28: 435-440
        • Lee J.Y.
        • Sohn K.H.
        • Rhee S.H.
        • et al.
        Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4.
        J. Biol. Chem. 2001; 276: 16683-16689
        • Kersten S.
        Mechanisms of nutritional and hormonal regulation of lipogenesis.
        EMBO Rep. 2001; 2: 282-286
        • Mendis S.
        • Arseculeratne Y.M.
        • Withana N.
        • et al.
        Chlamydia pneumoniae infection and its association with coronary heart disease and cardiovascular risk factors in a sample South Asian population.
        Int. J. Cardiol. 2001; 79: 191-196
        • Mendis S.
        • Athauda S.B.
        • Nase M.
        • Takahashi K.
        • et al.
        Association between hyperhomocysteinaemia and hypertension in Sri Lankans.
        J. Int. Med. Res. 1999; 27: 38-44
        • Lefebvre P.J.
        • Scheen A.J.
        The postprandial state and risk of cardiovascular disease.
        Diabetic Med. 1998; 15: S63-68
        • Jagla A.
        • Schrezenmeir J.
        Postprandial triglycerides and endothelial function.
        Exp. Clin. Endocrinol. Diabetes. 2001; 109: S533-547
        • Hennig B.
        • Toborek M.
        • McClain C.J.
        High-energy diets, fatty acids and endothelial cell function: implications for atherosclerosis.
        J. Am. Coll. Nutr. 2001; 20: 97-105
        • Brown A.A.
        • Hu F.B.
        Dietary modulation of endothelial function: implications for cardiovascular disease.
        Am. J. Clin. Nutr. 2001; 73: 673-686
        • Abeywardena M.Y.
        • Head R.J.
        n-3 Polyunsaturated fatty acids and blood vessel function.
        Cardiovasc. Res. 2001; 52: 361-371
        • Lichtenstein A.H.
        • Van Horn L.
        Very low fat diets––American Heart Association Science advisory report.
        Circulation. 1998; 98: 935-939
        • Reaven G.M.
        Diet and Syndrome X.
        Curr. Atheroscler. Rep. 2000; 2: 503-507
      4. Popkin BM, Horton S, Kim S. The nutritional transition and diet-related chronic diseases in Asia-Implication for prevention, International Food Policy Research Institute, 2001; FCND-Discussion paper No. 105; http://www.ifpriorg/checknames.cfm/fcndp105.pdfname=fcndp105.pdfadirec=d:\webs\ifpri\divs\fcnd\dp\papers.

        • Simmons D.
        • Williams R.
        Dietary practises among Europeans and different South Asian groups in Coventry.
        Br. J. Nutr. 1997; 78: 5-14
        • Weerasuriya N.
        • Siribaddana S.
        • Dissanayake A.
        • et al.
        Long-term complications in newly diagnosed Sri Lankan patients with type 2 diabetes mellitus.
        Q. J. Med. 1998; 91: 439-443
        • Fernando D.J.
        • Siribaddana S.
        • Perera N.
        • et al.
        The prevalence of macrovascular disease and lipid abnormalities amongst diabetic patients in Sri Lanka.
        Postgrad. Med. J. 1993; 69: 557-561
        • Duplain H.
        • Burcellin R.
        • Satori C.
        • et al.
        Insulin resistance, hyperlipidemia and hypertension in mice lacking endothelial nitric oxide synthase.
        Circulation. 2001; 4: 342-345
        • Kurowska E.M.
        Nitric oxide therapies in vascular diseases.
        Curr. Pharm. Des. 2002; 8: 155-166
        • Miyazaki H.
        • Matsuoka H.
        • Cooke J.P.
        • et al.
        Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis.
        Circulation. 1999; 99: 1141-1146
        • Cooke J.P.
        Does ADMA cause endothelial dysfunction.
        Arterioscler. Thromb. Vasc. Biol. 2000; 20: 2032-2037
        • Valkonen V.P.
        • Oaiva H.
        • Salonen J.T.
        • et al.
        Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine.
        Lancet. 2001; 358: 2127-2128
        • Stulingher M.C.
        • Abbasi F.
        • Chu J.W.
        • et al.
        Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor.
        J. Am. Med. Assoc. 2002; 287: 1420-1426
        • Narasinga Rao B.S.
        Palm oil use and compatibility in India.
        Food Nutr. Bull. 1994; 15: 149-157